Home > News > Content

Cardiac Troponin Market Analysis, Market Size, Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2017 To 2021

Oct 30, 2017

Cardiac markers are used as traceable substances while diagnosing patients with chest pain and suspected acute coronary syndrome (ACS). Cardiac troponins are one of the cardiac biomarkers or diagnostic markers centralized to myocardial infarction or heart muscle cell death diagnosis. Troponin is found in skeletal muscle and cardiac muscle of human body, thus increased level of the cardiac troponin circulating in the blood represents the susceptibility of myocardial infarction.

The growth of the U.S. cardiac troponin market is driven by increase in demand for cardiac biomarkers for cardiovascular disease diagnosis, rise in incidence of acute coronary syndrome (ACS), advancements in the cardiac biomarkers, and growth in demand for point-of-care cardiac testing kits. High specificity and sensitivity of these markers to detect any cardiac disorders and development of new products by the key market players contribute towards the market growth.